U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
148891148891Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational StudyCompletedNo Results AvailableOsteoarthritis|Arthritis, Rheumatoidhttps://ClinicalTrials.gov/show/NCT00612885
148892148892Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy SubjectsTerminatedNo Results AvailableParkinson Disease|Alzheimer Disease|Healthy Controls|Multiple SclerosisDrug: [123I]CLINDEhttps://ClinicalTrials.gov/show/NCT00612872
148893148893Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)CompletedNo Results AvailableAnxiety DisordersDrug: levetiracetamhttps://ClinicalTrials.gov/show/NCT00612859
148894148894Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk PatientsTerminatedNo Results AvailableCholedocholithiasis|Higher Risk PatientsProcedure: Endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy|Procedure: Laparoscopic bile duct exploration during cholecystectomyhttps://ClinicalTrials.gov/show/NCT00612846
148895148895A Randomized Controlled Trial of Three Vasectomy TechniquesTerminatedNo Results AvailableContraceptionProcedure: Vasectomy occlusion techniqueshttps://ClinicalTrials.gov/show/NCT00612833
148896148896A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNo Results AvailableAllergic Rhinitis|Rhinitis, Allergic, SeasonalDrug: GSK256066|Drug: fluticasone propionatehttps://ClinicalTrials.gov/show/NCT00612820
148897148897Treatment of Mood and Marriage Study (TOMMS)CompletedHas ResultsMajor Depressive Disorder|Partner Relational Disorder (V61.10)Behavioral: Weekly marital therapy|Drug: As indicated: Sertraline, bupropion, venlafaxine, mirtazepine, nortriptyline, tranylcypromine, lithium augmentation, etc.https://ClinicalTrials.gov/show/NCT00612807
148898148898A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: exenatide once weekly|Drug: placebohttps://ClinicalTrials.gov/show/NCT00612794
148899148899Yellow Versus White StudyCompletedNo Results AvailableCataractProcedure: cataract surgery (Hoya AF-1 [UY] YA-60BB)|Procedure: cataract surgery (Hoya AF-1 [UV] VA-60BB lens)https://ClinicalTrials.gov/show/NCT00612781
148900148900Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP FormulationsCompletedNo Results AvailableDermatitis, ContactBiological: TRUE TEST Skin patch test Bioequivalencehttps://ClinicalTrials.gov/show/NCT00612768
148901148901Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4CompletedNo Results AvailableHIV Infections|Hepatitis CDrug: Peginterferon alfa-2a + ribavirinhttps://ClinicalTrials.gov/show/NCT00612755
148902148902Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenCompletedNo Results AvailableHypoactive Sexual Desire DisorderDrug: testosterone gel|Drug: placebo gelhttps://ClinicalTrials.gov/show/NCT00612742
148903148903Light Filters in Intraocular Lenses (IOLs) and Its Influence on Colour and Contrast Vision.CompletedNo Results AvailableCataractProcedure: Polylens Y30 intraocular lens|Procedure: Orange Series Model PC 440 Y intraocular lenshttps://ClinicalTrials.gov/show/NCT00612729
148904148904Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaRecruitingNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma and Plasma Cell NeoplasmDrug: busulfan|Drug: cyclophosphamide|Biological: Stem cell infusion|Radiation: Total body irradiationhttps://ClinicalTrials.gov/show/NCT00612716
148905148905A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid TumorsCompletedNo Results AvailableCancerDrug: ARQ 197https://ClinicalTrials.gov/show/NCT00612703
148906148906School-Based Mental Health Services for Urban ChildrenCompletedHas ResultsConduct Disorder|Oppositional Defiant Disorder|Attention Deficit Disorder With HyperactivityBehavioral: Community mental health consultation model program|Behavioral: Treatment as usual (TAU)https://ClinicalTrials.gov/show/NCT00612690
148907148907Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemTerminatedHas ResultsLung CancerDrug: Oxaliplatin|Drug: Pemetrexedhttps://ClinicalTrials.gov/show/NCT00612677
148908148908Phase II, 2nd Line Melanoma - RAND MonotherapyCompletedNo Results AvailableMelanomaDrug: Anti-CD137 (4-1BB) (BMS-663513)https://ClinicalTrials.gov/show/NCT00612664
148909148909PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant GliomasCompletedNo Results AvailableGliosarcoma|Glioblastoma|Anaplastic AstrocytomaDrug: Temodar and SCH 66336https://ClinicalTrials.gov/show/NCT00612651
148910148910Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic GliomasCompletedNo Results AvailableGlioblastoma|GliosarcomaDrug: Temodar, O6-BG, and Irinotecanhttps://ClinicalTrials.gov/show/NCT00612638
148911148911Near Normalisation of BG Improves the Potentiating Effect of GLP-1CompletedNo Results AvailableDiabetes Mellitus Type 2Drug: glucagon-like peptide-1|Drug: Salinehttps://ClinicalTrials.gov/show/NCT00612625
148912148912Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaTerminatedNo Results AvailableB-cell Chronic Lymphocytic Leukemia|Leukemia|Prolymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Stage I Chronic Lymphocytic Leukemia|Stage II Chronic Lymphocytic Leukemia|Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic LeuDrug: obatoclax mesylate|Drug: fludarabine phosphate|Biological: rituximab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00612612
148913148913Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: biphasic insulin asparthttps://ClinicalTrials.gov/show/NCT00612599
148914148914Phase 2 Study of Enzastaurin With 5 FU/LV Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon CancerCompletedNo Results AvailableColorectal CancerDrug: Enzastaurin|Drug: Placebo|Drug: Leucovorin|Drug: 5-FU|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00612586
148915148915Treatment of Moderate to Severe Facial Acne VulgarisCompletedHas ResultsAcne VulgarisDrug: Doxycycline 0.6 mg/kg/day|Drug: Doxycycline 1.2 mg/kg/day|Drug: Doxycycline 2.4 mg/kg/day|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00612573
148916148916Flaxseed, Aromatase Inhibitors and Breast Tumor CharacteristicsCompletedNo Results AvailableBreast CancerDrug: Anastrozole|Dietary Supplement: flaxseed|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00612560
148917148917ACT for the Home Management in Malagasy ChildrenCompletedNo Results AvailableFever|Suspected MalariaDrug: Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam)https://ClinicalTrials.gov/show/NCT00612547
148918148918A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee ReplacementCompletedHas ResultsPost Operative PainDrug: Sufentanil NanoTab|Drug: Placebo NanoTab|Drug: Sufentanil NanoTab|Drug: Sufentanil NanoTabhttps://ClinicalTrials.gov/show/NCT00612534
148919148919Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting MyonecrosisTerminatedNo Results AvailableCoronary Artery Stenosis|Coronary Artery DiseaseDrug: Adenosinehttps://ClinicalTrials.gov/show/NCT00612521
148920148920Hormonal Contraception and Vaginal HealthCompletedHas ResultsContraceptive Usage|Vaginal Epithelial DisruptionDrug: Desogen (ethinyl estradiol and desogestrel)|Drug: NuvaRing (ethinyl estradiol and etonogestrel)https://ClinicalTrials.gov/show/NCT00612508

* Görseller ve İçerik tekif hakkına sahip olabilir